Akademibokhandeln
Pukar Khanal, Kunal Bhattacharya - Molecular Basis and Translational Strategies in Neurodegenerative Diseases, Inbunden

Inbunden, Engelska, 2027

Molecular Basis and Translational Strategies in Neurodegenerative Diseases

Av Pukar Khanal, Kunal Bhattacharya

2369 kr

Kommande

Beskrivning
This book explores the evolving landscape of neurodegenerative disease research, integrating foundational knowledge with emerging therapeutic paradigms. It examines the pathophysiology of neurodegeneration, emphasizing epigenetic regulation, protein misfolding, metabolic dysfunction, and neuroimmune interactions. The chapters highlight current and next-generation interventions, including immunotherapy, neuroprotective agents, stem cell-based regenerative approaches, antisense oligonucleotides, and nanotechnology-driven drug delivery systems. It also covers systems biology, neuroimaging, and neuromodulation techniques such as transcranial magnetic stimulation and deep brain stimulation. Special focus is given to public health strategies, microbiota-gut-brain interactions, and the ethical-legal dimensions of care.Key PointsOffers an in-depth understanding of the molecular and cellular mechanisms underlying major neurodegenerative disorders.Explores therapeutic innovations including gene editing, immunotherapy, antisense oligonucleotides, and regenerative medicine.Examines cross-disciplinary approaches such as systems biology, neuroimaging biomarkers, and neuromodulation strategies.Addresses translational challenges, public health interventions, ethical concerns, and patient-centered care.Highlights future directions in neurodegeneration research, integrating emerging technologies like AI and nanomedicine.
Produktinformation
  • Utgivningsdatum: 2027-04-28
  • Mått: 156 x 234 x undefined mm
  • Format: Inbunden
  • Språk: Engelska
  • Antal sidor: 440
  • Förlag: Taylor & Francis Ltd
  • ISBN: 9781041170372
Utforska kategorier
Mer information

Dr. Pukar Khanal is a pharmacological researcher with expertise in drug discovery and translational biomedical research. He holds a PhD in Pharmaceutical Sciences and has conducted postdoctoral research applying multi-omics and translational bioinformatics/pharmacology/chemical biology to explore novel therapeutic strategies against Alzheimer’s disease beyond amyloid, tau, and cholinergic hypotheses. His research integrates computational and experimental approaches to identify therapeutic targets and small molecules for complex diseases. His current interests focus on geroneuroprotectors for major depressive disorder and neuroprogressive disorders, including Alzheimer’s disease, with emphasis on post-translationally modified proteins for currently undruggable targets. He is also a co-editor of the book Neuroinflammation and Autophagy in Neurodegeneration (Springer Nature), Associate Editor for Ethnopharmacology (Frontiers in Pharmacology), Nutrition and Food Science Technology (Frontiers in Nutrition), and has hosted multiple research topics on targeted drug delivery against neuroinflammation in neurodegeneration. Further, he is an Editor of Pharmacological Research—Reports and has served in editorial capacities, including CNS & Neurological Disorders—Drug Targets, Stem Cells International, International Journal of Genomics, and Journal of Applied Pharmaceutical Science. In addition, he is an experienced scientist with extensive experience in teaching, research supervision, and multidisciplinary scientific collaboration. His interdisciplinary background in pharmacology and computational and experimental research enables him to contribute to advancing modern approaches to drug discovery.Dr. Kunal Bhattacharya is a Professor (Associate) of Pharmaceutical Chemistry at the Pratiksha Institute of Pharmaceutical Sciences, Guwahati, Assam, India. He holds a Ph.D. in Pharmaceutical Sciences with research specialization in Alzheimer’s disease and has expertise in computational drug discovery, bioinformatics, molecular modelling, network pharmacology, cheminformatics, and natural product-based drug development. His research primarily focuses on neurodegenerative disorders, mostly Alzheimer’s disease, integrating computational and experimental approaches for drug discovery. Dr. Bhattacharya has authored numerous research articles, reviews, and book chapters in internationally reputed journals and has co-edited the CRC Press book Computational and Experimental Studies in Alzheimer’s Disease. He is also actively involved in academic publishing as an Associate Editorial Board Member and Associate/Review Editor for international journals and serves as a reviewer for journals published by Springer Nature, Elsevier, Wiley, Taylor & Francis, Frontiers, and other major publishers. His research contributions have also resulted in multiple granted patents and prestigious IASc-INSA-NASI and Council of Scientific and Industrial Research summer research fellowships.

Butikslager

Ej i lager i butik.

Betyg & recensioner

0 recensioner

Inga recensioner tillgängliga.